CVS Health Corporation (CVS) : CVS Health Corporation (CVS) had a healthy money flow of $5.04 million into the stock during the Wednesdays trading session. The value of bullish trades on upticks was $21.57 million, whereas, investors only sold shares worth $16.53 million on downticks. The stock closed the day with an up-down ratio of 1.3.The money flow in the block trades to the tune of $4.72 million shows that the bulls were dominant, the large players used the weakness in the stock to accumulate it for the long-term. $7.15 million worth of transactions were on upticks. A paltry $2.42 million worth of block trade transactions on downticks shows that the investors are reluctant to sell the stock down. The total up-down ratio of the upticks vs the downticks in block trades was 2.95. CVS Health Corporation (CVS) stock slid $0.09 intraday and traded at 96.82, a change of -0.09% over previous days close. However, for the week, the company shares are -0.28% compared to previous weeks close.
Also, Equity Analysts at the Brokerage Firm, Morgan Stanley, downgrades their rating on the shares of CVS Health Corporation (NYSE:CVS). Morgan Stanley has a Equal-weight rating on the shares. As per the latest research report, the brokerage house lowers the price target to $104 per share from a prior target of $111. The rating by the firm was issued on June 20, 2016.
CVS Health Corporation (NYSE:CVS): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $97.26 and $96.65 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $97.37. The buying momentum continued till the end and the stock did not give up its gains. It closed at $97.00, notching a gain of 0.10% for the day. The total traded volume was 3,485,961 . The stock had closed at $96.90 on the previous day.
The stock has recorded a 20-day Moving Average of 2.04% and the 50-Day Moving Average is 0.01%. In a related news,The director officer (President and CEO) of Cvs Health Corp, Merlo Larry J sold 38,247 shares at $105 on May 5, 2016. The Insider selling transaction had a total value worth of $4,015,935. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.
CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise, including over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, photo finishing, seasonal merchandise and greeting cards through the Companys retail stores, online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company, through its wholly owned subsidiary, Omnicare, Inc., provides pharmacy services to long term care facilities.